|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.29 USD | +0.10% |
|
+0.98% | -40.15% |
| 05-13 | Omeros Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Omeros Q1 Adjusted Loss Narrows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OMEROS CORPORATION | Bio Therapeutic Drugs | +6.64% | +0.98% | -40.15% | +219.25% | -31.74% | 744M |  | |  |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
